Amsbio announces an innovative range of Induced Pluripotent Stem Cell (iPSC) kits for researchers requiring a rapid, reproducible, and scalable means of generating specific neural cell types without sacrificing cell purity.
These kits use simple, highly reproducible protocols to ensure experimental consistency. These streamlined protocols allow researchers to efficiently differentiate iPSCs into target neural cells within just 1-2 weeks. Scientists can now produce neurons as needed, ensuring greater flexibility and control in design of disease modelling, regenerative medicine, and drug…
Mursla Bio Introduces AI Precision Medicine Platform Built on Organ-Specific EV Isolation from Blood
Platform is built on biologically labelled, organ-specific multi-omics data carried by extracellular vesicles isolated from 2ml plasma samples
Enables differentiated AI-powered biomarker discovery and IVD translation for patient stratification, therapeutic monitoring, surrogate markers and other diagnostic development programs
Publication of pre-print data, with support from Evotec International GmbH and University College London demonstrates validation of Platform’s capability for liver diseases
Cambridge, UK, and Boston MA, USA, 17 June 2025: Mursla Bio, a leader in Extracellular…
Devens, MA, USA — Veranova, a global leader in the development and manufacturing of specialist and complex active pharmaceutical ingredients (APIs) for the pharmaceutical and biotech sectors, today announced a strategic investment to establish state-of-the-art bioconjugation development and cGMP manufacturing capacity at its Devens, Massachusetts campus.
This expansion will enable Veranova to provide a more comprehensive suite of services to partners developing antibody-drug conjugates (ADCs) and other bioconjugates, and builds on the Devens facility’s extensive experience in the development…
As global companies compete fiercely for top-tier talent, those with a foothold in Cambridge now have an unprecedented advantage: corporate housing designed specifically to attract and retain the best. Present Made, Eddington, is leading the way with Cambridge’s first purpose-built, large-scale corporate letting scheme – a pioneering development that brings 21st-century executive living to one of the UK’s most dynamic science and technology hubs. With 56 houses and 130 high-spec apartments available for corporate leasing, this development is more than just accommodation – it’s a talent…
Five new ventures secure the chance to be part of Babraham Research Campus - a leading location for early-stage life science start-ups
Cambridge, 12th June 2025: Five life science start-ups focused on the development of new technology, products and services to positively impact future healthcare have been selected to participate in Babraham Research Campus’ accelerator programme, Accelerate@Babraham.
Held annually, Accelerate@Babraham is now in its seventh year. Since its inception, the programme has supported 32 early-stage enterprises and earlier this year…
Extends capabilities of industry-leading PhysioMimix DILI assay for comparative studies between animal species and human
Generates deeper insights into inter-species differences to de-risk development pipelines and minimize animal testing
Cambridge, UK, 10 June 2025: CN Bio, a leading provider of Organ-on-a-chip (OOC) systems and solutions that accelerate drug discovery and development workflows, has introduced two new animal microphysiological system (MPS) models that enhance translatability in preclinical drug safety and toxicology assessments to its Contract Research Services (CRS…
Wickman House: Premium Staff Accommodation in the Heart of North Cambridge198 Green End Road, Chesterton, Cambridge, CB4
In a city where demand for talent is matched only by the need for quality housing, Wickman House offers forward-thinking employers a strategic opportunity to secure accommodation for their workforce.
This brand-new, purpose-built Build to Rent development comprises nine high-quality apartments in the well-connected neighbourhood of Chesterton, just minutes from Cambridge Science Park, Cambridge Business Park, and St John’s Innovation Centre. It’s the perfect base for staff…
Global drug development consultancy Boyds has announced the appointment of Lisa Allenby as Associate Director, Regulatory Operations.
Lisa has more than 25 years’ experience in regulatory operations, having previously worked at DLRC Regulatory Consultancy and pharmaceutical company Mylan. She has extensive experience of managing major filings across the globe, as well as leading cross-functional meetings representing regulatory operations in the submissions management process.
Lisa also has experience working with SMEs on key projects with the Medicines and Healthcare products Regulatory…
Cambridge, UK – 10 June 2025: Microbiotica, a clinical-stage biopharma company developing a pipeline of oral precision microbiome medicines called live biotherapeutic products (LBPs), announces that Dr Robert Tansley is appointed Chief Medical Officer with immediate effect.
Dr Tansley steps into the role at a key development stage for Microbiotica with its two lead programmes progressing through Phase 1 clinical trials in immuno-oncology (MB097 for advanced melanoma), and inflammatory bowel disease (MB310 for ulcerative colitis) with data read-outs anticipated this year.
Dr Robert Tansley…
Life Science Agency CLOK are proud to announce the opening of new high-tech offices situated between Sherwood Pines and Center Parcs. Designed to support innovation and collaboration, the state-of-the-art space offers ultra-fast connectivity and top-tier facilities. A premium working environment reflects the organisations commitment to excellence, providing a clean air, friendly environment that is surrounded by acres of greenspace. The new office is located with excellent transport links for both clients and team members, with free on-site parking and great local amenities, including…